Faculty, Staff and Student Publications
Publication Date
1-4-2023
Journal
Cancer Prevention Research
Abstract
Bexarotene is a rexinoid that has been shown to prevent mammary tumors in mouse models but oral dosing has toxicities. This phase I study evaluates topical bexarotene, as a potential chemoprevention agent, for safety and toxicity in high-risk women for breast cancer.
Keywords
Female, Bexarotene, Neoplasms, Humans, Administration, Topical, Antineoplastic Agents
DOI
10.1158/1940-6207.CAPR-22-0210
PMID
36228112
PMCID
PMC10391360
PubMedCentral® Posted Date
August 2023
PubMedCentral® Full Text Version
Author MSS
Published Open-Access
yes
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Community Health and Preventive Medicine Commons, Medical Sciences Commons, Obstetrics and Gynecology Commons, Oncology Commons, Women's Health Commons
Comments
Trial registration: ClinicalTrials.gov NCT02876640.